Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts

Journal of Virology

Volumn 85, Issue 23, 2011, Pages 12292-12303

  Ali, Naushad ^a   Allam, Heba ^a   May, Randal ^a   Sureban, Sripathi M ^a   Bronze, Michael S ^a   Bader, Ted ^a   Umar, Shahid ^a   Anant, Srikant ^b   Houchen, Courtney W ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CD133 ANTIGEN; CELL MARKER; CYTOKERATIN 19; DOUBLECORTIN AND CAM KINASE LIKE 1; MATRIGEL; MYC PROTEIN; NONSTRUCTURAL PROTEIN 5B; PROTEIN; PROTEIN LGR5; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL LIKE CELL; CARCINOGENESIS; CELL CULTURE; CELL ISOLATION; CELL LINE; CONTROLLED STUDY; DRUG TARGETING; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; ONCOGENE SRC; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; SPHEROID CELL; TISSUE MICROARRAY; TUMOR; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOENZYME TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATIN-19; LIVER; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REPLICON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA, VIRAL; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

HEPATITIS C VIRUS; MURINAE;

EID: 81255200425     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05920-11     Document Type: Article

References (63)

1. Ali, N., K. D. Tardif, and A. Siddiqui. 2002. Cell-free replication of the hepatitis C virus subgenomic replicon. J. Virol. 76:12001-12007.
2. Alison, M. R. 2005. Liver stem cells: implications for hepatocarcinogenesis. Stem Cell Rev. 1:253-260.
3. Allam, H., and N. Ali. 2010. Initiation factor eIF2-independent mode of c-Src mRNA translation occurs via an internal ribosome entry site. J. Biol. Chem. 285:5713-5725.
4. Aoi, T., et al. 2008. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321:699-702.
5. Bartenschlager, R., F. L. Cosset, and V. Lohmann. 2010. Hepatitis C virus replication cycle. J. Hepatol. 53:583-585.
6. Bartosch, B., R. Thimme, H. E. Blum, and F. Zoulim. 2009. Hepatitis C virus-induced hepatocarcinogenesis. J. Hepatol. 51:810-820.
7. Blight, K. J., J. A. McKeating, and C. M. Rice. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76:13001-13014.
8. Ding, S. J., et al. 2004. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol. Cell. Proteomics 3:73-81.
9. Engels, B. M., T. G. Schouten, J. van Dullemen, I. Gosens, and E. Vreugdenhil. 2004. Functional differences between two DCLK splice variants. Brain Res. Mol. Brain Res. 120:103-114.
10. Farazi, P. A., and R. A. DePinho. 2006. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer. 6:674-687.
11. Fried, M. W., et al. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347:975-982.
12. Fukasawa, M. 2010. Cellular lipid droplets and hepatitis C virus life cycle. Biol. Pharm. Bull. 33:355-359.
13. Gale, M., Jr., and E. M. Foy. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436:939-945.
14. Guo, J. T., V. V. Bichko, and C. Seeger. 2001. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 75:8516-8523.
15. Jia, F., et al. 2010. A nonviral minicircle vector for deriving human iPS cells. Nat. Methods 7:197-199.
16. Kaji, K., et al. 2009. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458:771-775.
17. Kim, J. B., et al. 2009. Direct reprogramming of human neural stem cells by OCT4. Nature 461:649-653.
18. Kim, M. H., et al. 2003. The DCX-domain tandems of doublecortin and doublecortin-like kinase. Nat. Struct. Biol. 10:324-333.
19. Lai, C. K., K. S. Jeng, K. Machida, and M. M. Lai. 2008. Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A. J. Virol. 82:8838-8848.
20. Lazaro, C. A., et al. 2007. Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am. J. Pathol. 170:478-489.
21. Lee, H. C., M. Kim, and J. R. Wands. 2006. Wnt/Frizzled signaling in hepatocellular carcinoma. Front. Biosci. 11:1901-1915.
22. Lee, J. S., et al. 2006. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat. Med. 12:410-416.
23. Levrero, M. 2006. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:3834-3847.
24. Lin, P. T., J. G. Gleeson, J. C. Corbo, L. Flanagan, and C. A. Walsh. 2000. DCAMKL1 encodes a protein kinase with homology to doublecortin that regulates microtubule polymerization. J. Neurosci. 20:9152-9161.
25. Lindenbach, B. D., and C. M. Rice. 2005. Unravelling hepatitis C virus replication from genome to function. Nature 436:933-938.
26. Lowry, W. E., et al. 2008. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 105:2883-2888.
27. Manns, M. P., et al. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358:958-965.
28. Marquardt, J. U., V. M. Factor, and S. S. Thorgeirsson. 2010. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. J. Hepatol. 53:568-577.
29. May, R., et al. 2008. Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells 26:630-637.
30. May, R., et al. 2009. Doublecortin and CaM kinase-like-1 and leucine-richrepeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively. Stem Cells 27:2571-2579.
31. May, R., et al. 2010. Identification of a novel putative pancreatic stem/ progenitor cell marker DCAMKL-1 in normal mouse pancreas. Am. J. Physiol. Gastrointest. Liver Physiol. 299:G303-G310.
32. Mellor, J., E. C. Holmes, L. M. Jarvis, P. L. Yap, and P. Simmonds. 1995. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J. Gen. Virol. 76(Pt. 10):2493-2507.
33. Mishra, L., et al. 2009. Liver stem cells and hepatocellular carcinoma. Hepatology 49:318-329.
34. Moradpour, D., et al. 2004. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J. Virol. 78:7400-7409.
35. Moradpour, D., F. Penin, and C. M. Rice. 2007. Replication of hepatitis C virus. Nat. Rev. Microbiol. 5:453-463.
36. Nakanishi, T., et al. 2010. Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expres- sion and signalling. Br. J. Cancer 102:815-826.
37. Nelson, H. B., and H. Tang. 2006. Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression. J. Virol. 80:1181-1190.
38. Park, C. Y., et al. 2009. Nonstructural 5A protein activates beta-catenin signa cascades: implication of hepatitis C virus-induced liver pathogenesis. J. Hepatol. 51:853-864.
39. Park, I. H., et al. 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146.
40. Parkin, D. M. 2001. Global cancer statistics in the year 2000. Lancet Oncol. 2:533-543.
41. Poenisch, M., and R. Bartenschlager. 2010. New insights into structure and replication of the hepatitis C virus and clinical implications. Semin. Liver Dis. 30:333-347.
42. Qu, L., and S. M. Lemon. 2010. Hepatitis A and hepatitis C viruses: diver- gent infection outcomes marked by similarities in induction and evasion of interferon responses. Semin. Liver Dis. 30:319-332.
43. Raychoudhuri, A., et al. 2010. Hepatitis C virus infection impairs IRF-7 and alpha interferon synthesis in immortalized human hepatocytes. J. Virol. 84:10991-10998.
44. Roohvand, F., et al. 2009. Initiation of hepatitis C virus infection requires the dynamic microtubule network: role of the viral nucleocapsid protein. J. Biol. Chem. 284:13778-13791.
45. Rosen, H. R. 2011. Clinical practice. Chronic hepatitis C infection. N. Engl. J. Med. 364:2429-2438.
46. Shi, G. M., et al. 2008. Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. J. Cancer Res. Clin. Oncol. 134:1155-1163.
47. Sun, C., X. L. Jin, and J. C. Xiao. 2006. Oval cells in hepatitis B virus-positive and hepatitis C virus-positive liver cirrhosis: histological and ultrastructural study. Histopathology 48:546-555.
48. Sureban, S. M., et al. 2009. Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism. Gastroenterology 137:649-659.
49. Tardif, K. D., G. Waris, and A. Siddiqui. 2005. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol. 13:159-163.
50. Thompson, M. D., and S. P. Monga. 2007. WNT/beta-catenin signaling in liver health and disease. Hepatology 45:1298-1305.
51. Tsamandas, A. C., et al. 2006. Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: a clinicopathologic study. Liver Int. 26:817-826.
52. Wakita, T., et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
53. Waris, G., K. D. Tardif, and A. Siddiqui. 2002. Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. Biochem. Pharmacol. 64:1425-1430.
54. Wolk, B., B. Buchele, D. Moradpour, and C. M. Rice. 2008. A dynamic view of hepatitis C virus replication complexes. J. Virol. 82:10519-10531.
55. Woo, H. G., et al. 2010. Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. Cancer Res. 70:3034-3041.
56. Wu, P. C., et al. 1996. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am. J. Pathol. 149:1167-1175.
57. Wurmbach, E., et al. 2007. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45:938-947.
58. Yang, J. D., and L. R. Roberts. 2010. Epidemiology and management of hepatocellular carcinoma. Infect. Dis. Clin. North Am. 24:899-919.
59. Yang, J. D., and L. R. Roberts. 2010. Hepatocellular carcinoma: a global view. Nat. Rev. Gastroenterol. Hepatol. 7:448-458.
60. Yin, L., O. C. Velazquez, and Z. J. Liu. 2010. Notch signaling: emerging molecular targets for cancer therapy. Biochem. Pharmacol. 80:690-701.
61. Zhang, L., N. Theise, M. Chua, and L. M. Reid. 2008. The stem cell niche of human livers: symmetry between development and regeneration. Hepatology 48:1598-1607.
62. Zhao, D., et al. 2009. Derivation and characterization of hepatic progenitor cells from human embryonic stem cells. PLoS One 4:e6468.
63. Zulehner, G., et al. 2010. Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence. Am. J. Pathol. 176:472-481.